H2O2

Europe PMC · fetched just now · sorted by publication date

1. 1
   Combinatorial metabolic engineering of <i>Mycobacterium neoaurum</i> LY-2 for efficient androstenedione production from phytosterols.

   Xu L, Peng C, Pan W, Tong Y, Shi J, Xu Z, Li H. · 2026-08-19

   open access unreviewed
2. 2
   Unlocking raw-corncob consolidated bioprocessing for malic acid production by DyP-enabled lignin deconstruction in <i>Myceliophthora thermophila</i>.

   Zhang Y, Zhang Y, Han L, Liu J, Liu D, Sun T, Wang D, Li M, Li J, Tian C. · 2026-08-08

   open access unreviewed
3. 3
   Metabolic engineering of <i>Escherichia coli</i> for efficient production of d-phenylglycine.

   Xiong Y, Shang Z, Lu L, Wang T, Cai G, Shen X, Sun X, Wang J, Yuan Q. · 2026-08-07

   open access unreviewed
4. 4
   Reassigning an amber codon to selenocysteine using a functional cysteine suppression pair in <i>Escherichia coli</i>.

   Niu S, Wei J, Li M, Guo B, Yan Q, Huang Y, Jiang Z, Song J. · 2026-07-29

   open access unreviewed
5. 5
   Calcium dysregulation in synergy with sonodynamic therapy via medroxyprogesterone-targeted and ROS-responsive nanoparticles for endometrial cancer.

   Xiao B, Zhou J, Tang M, Li Y, Huang T, Liu J, Liu J, Yang L, Xiao H, Zhang L, Wang J. · 2026-09-23

   open access unreviewed
6. 6
   Engineered probiotics couple photothermal cuproptosis with biomechanical disruption and immune activation.

   Zhang X, Liu X, Huang K, Jin B, Ma N, Liu H, Jiang H, Wang X. · 2026-09-21

   open access unreviewed
7. 7
   Antifibrotic hydrogel strategies for scarless tissue regeneration: mechanisms, design, and application.

   Zhu S, Shi Y, Wang H, Feng L, Lu Y, Si X, Ma Q, He L, Liu S. · 2026-09-17

   open access unreviewed
8. 8
   A bladder microenvironment-adaptive ceria nanozyme hydrogel enables urea-responsive intravesical chemo-immunotherapy.

   Yuan Y, Yu L, Feng H, Li C, Chen X, Feng L, Pan T, Gao L, Zhou Y, Zhang L. · 2026-09-16

   open access unreviewed
9. 9
   Dismantling the eDNA-mediated H<sub>2</sub>S barrier with biohybrids against refractory biofilm infections.

   Yin M, Su M, Yi J, Ren Y, Zhang Y, Wu Q, Yang C, Xiao S, Gao C, Tang R, Cheng B, Xia J. · 2026-09-15

   open access unreviewed
10. 10
    Multienzymatic hybrid bio-heterojunction for synergistic microenvironment reprogramming and selenoprotein-activated mitochondrial bioenergetics in diabetic osseointegration.

    Zhang M, Lu M, Chen Y, Ming M, Luo B, Wu Y. · 2026-09-16

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.